Innovation Committee promotes new Charité projects

Berlin, 17.07.2023
The Innovation Committee at the Federal Joint Committee (G-BA) has selected a total of 35 new health services research projects for funding across Germany. Researchers from Charité – Universitätsmedizin Berlin are leading two of these projects, and Charité is involved in two others. The aim is to further develop and continuously improve health care. A current focus: transitions and interfaces in healthcare.
The Innovation Fund supports projects with model character that go beyond the current standard care. The insights gained set the course, as they are the basis for legal decisions. Prof. Dr. Liane Schenk, currently spokesperson of the Platform – Charité Health Services Research: “The projects that we can now implement focus increasingly on care processes in order to better understand and optimise health care processes, especially at the sector boundaries – for example between hospital and outpatient care. In order for this to succeed, a wide variety of data sources and methodological approaches are combined. The perspectives of all participants in the care process are included, whereby the perspective of the patients is central.
Project: E2-PSY – Evaluation of discharge management according to §39 paragraph 1a SGB V of (partially) inpatient psychiatrically treated people.
Head: Dr. Julie O’Sullivan, Institute for Medical Sociology and Rehabilitation Science, and Dr. Stefanie Schreiter, Department of Psychiatry and Psychotherapy, Charité Mitte Campus
Better care for people with Long COVID
Infection with COVID-19 can lead to long-term health consequences that are still far from being clarified and the care of which poses challenges for patients as well as for those treating them. In this project, researchers want to analyse the symptoms and current health care in detail so that those affected with the clinical picture of Long-COVID or Post-COVID can be better cared for in the future. Together with the BKK Dachverband e.V., they will collect and evaluate routine health insurance data throughout Germany over a period of two years. A group of patients will also be examined more closely and questioned in a standardised manner. An expert panel consisting of patients, outpatient care providers and other participating institutions will then review the results in order to derive recommendations for improved care. The aim is to develop guidelines for post-COVID patients and their primary care providers, who are often family doctors.
Project: LCovB – Improving the care situation of people affected by Long-COVID.
Head: Dr. Johanna Schuster, Institute for Medical Sociology and Rehabilitation Science, and Prof. Dr. Carmen Scheibenbogen, Acting Director of the Institute for Medical Immunology
The Charité is also involved as a consortium partner in the following projects:
Dissolve-E: Digitisation of a superordinate guideline register for an open, guideline-based, trustworthy treatment environment. The consortium is led by the Association of the Scientific Medical Societies (AWMF) e.V., and the project leader at Charité is Prof. Dr. Sylvia Thun, Core Unit Digital Medicine and Interoperability, Berlin Institute of Health at Charité (BIH).
NUTSEN: New therapies for rare diseases using the example of the so-called neuromyelitis optica spectrum disease (NMOSD). The consortium is led by the Klinikum rechts der Isar of the Technical University of Munich, the project leader at the Charité is Prof. Dr. Friedemann Paul, Experimental and Clinical Research Center (ECRC).
Project funding by the Innovation Committee
Since 2016, the Federal Joint Committee (G-BA) has been mandated to promote new forms of health care that go beyond the current standard care and health care research projects that are aimed at gaining knowledge to improve existing health care in the statutory health insurance system. In order to realise funding from the Innovation Fund, an Innovation Committee was established at the G-BA. The legally envisaged funding amount for new forms of health care and health services research is 200 million euros in each of the years 2020 to 2024. 80 percent of the funds are to be used for the promotion of new forms of health care, 20 percent of the funds for the promotion of health services research. The innovation fund is financed by the statutory health insurance funds from the health fund.